Aspartic Acid

Aspartic Acid

SCHEMBL7309528

CC(=O)Br.CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)O.N[C@@H](CC(=O)O)C(=O)O

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SSTR1SSTR2SSTR3SSTR5

The experimentally established mechanism targets of Aspartic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 3/20 0.52
CTSL P07711 4/20 0.49
CTSS P25774 3/20 0.49
CTSB P07858 3/20 0.49
ECE1 P42892 2/20 0.49
CTSK P43235 2/20 0.49
MME P08473 1/20 0.49
SLC1A3 P43003 1/20 0.47
SLC1A1 P43005 1/20 0.47
CA2 P00918 1/20 0.47
CA5A P35218 1/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
LMNA P02545 1/20 0.46
CA1 P00915 1/20 0.46
ELANE P08246 2/20 0.45
PRTN3 P24158 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Aspartic Acid SCHEMBL9069992 0.98 CASP3 (0.50) CASP3CTSLCTSSCTSBECE1
Isopropylamine SCHEMBL10558459 0.86 CTSL (0.59) CASP3CTSLCTSSCTSBECE1
Alanine SCHEMBL5485711 0.84 CTSL (0.58) CASP3CTSLCTSSCTSBECE1
SCHEMBL8671882 0.84 CTSL (0.63) CASP3CTSLCTSSCTSBECE1
SCHEMBL1287168 0.84 CTSL (0.63) CASP3CTSLCTSSCTSBECE1
SCHEMBL220569 0.84 CTSL (0.63) CASP3CTSLCTSSCTSBECE1
SCHEMBL2978398 0.84 CTSL (0.63) CASP3CTSLCTSSCTSBECE1
Glycine SCHEMBL8365362 0.83 CTSL (0.57) CASP3CTSLCTSSCTSBECE1
Valine SCHEMBL5917142 0.82 CTSL (0.56) CASP3CTSLCTSSCTSBECE1
Alanine SCHEMBL7446206 0.82 CTSL (0.48) CASP3CTSLCTSSCTSBECE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5843905-A Peptidic phosphinyloxymethyl ketones as interleukin-1β-converting enzyme inhibitors VERTEX PHARMACEUTICALS, INCORPORATED (US) 1998-12-01 US disclosed
EP-0644197-B1 Peptidic phosphinyloxymethyl ketones as interleukin-1beta-converting enzyme inhibitors VERTEX PHARMA (US) 1998-09-09 EP disclosed
US-5677283-A α-heteroaryloxymethyl ketones as interleukin - 1 β converting enzyme inhibitors SANOFI (FR) 1997-10-14 US disclosed
US-5585357-A Heteroaryloxymethyl ketones as interleukin-1βconverting enzyme inhibitors SANOFI WINTHROP INC. (US) 1996-12-17 US disclosed
EP-0644198-A1 Alpha-heteroaryloxymethyl ketones as interleukin-1beta converting enzyme inhibitors STERLING WINTHROP INC. (US) 1995-03-22 EP disclosed
EP-0644197-A1 Peptidic phosphinyloxymethyl ketones as interleukin-1beta-converting enzyme inhibitors STERLING WINTHROP INC. (US) 1995-03-22 EP disclosed